Stephen Morrell
Family Medicine · Layton, UTNPI 1801872601
Payments from drug & device makers
Across 167 payments — averaging $14.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$639
- Boehringer Ingelheim$224
- GSK$170
- Novo Nordisk$155
- Lilly USA, LLC$131
- Amarin Pharma, Inc.$107
- plus $1K from 32 others
What the payments were for
- Food & beverage$2,427100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 47 | $639 |
| Boehringer Ingelheim | 12 | $224 |
| GSK | 12 | $170 |
| Novo Nordisk | 11 | $155 |
| Lilly USA, LLC | 10 | $131 |
| Amarin Pharma, Inc. | 7 | $107 |
| Abbott | 5 | $102 |
| Johnson & Johnson | 7 | $100 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $57 |
| Organon | 5 | $54 |
| Dynavax Technologies Corporation | 4 | $48 |
| Astellas Pharma US Inc | 3 | $47 |
| Ironshore Pharmaceuticals Inc. | 3 | $45 |
| Amgen | 2 | $41 |
| AstraZeneca | 3 | $41 |
| Nalpropion Pharmaceuticals LLC | 3 | $37 |
| Pfizer | 3 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $33 |
| Cranial Technologies, Inc | 2 | $32 |
| Genentech USA, Inc. | 2 | $32 |
| Idorsia Pharmaceuticals US Inc | 2 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Alfasigma USA, Inc. | 1 | $18 |
| Merck | 1 | $17 |
| Strongbridge US Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Eisai Inc. | 1 | $13 |
| Novartis | 1 | $13 |
| Sobi, Inc | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $12 |
| Medtronic | 1 | $12 |
| Shire North American Group Inc | 1 | $11 |
How this compares
$2,427 in reported general payments places this provider in the 70th percentile of 928 family medicine providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 17 | $254 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Layton
- Marc AndersonLayton$2.8M
- Jeffery DegrauwLayton$921K
- Kurtis WoolfLayton$224K
- Courtney NelsonLayton$190K
- David ButtersLayton$189K
- John HemmersmeierOgden$24.9M
- Judith KirsteinWest Jordan$22.7M
- Matthew JohnstonSalt Lake City$20.9M
- Jared ProbstSalt Lake City$18.8M
- Bryce PetersonBountiful$16M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.